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Abstract: Periprosthetic joint infection continues to frustrate the medical community. Although the demand for total joint
arthroplasty is increasing, the burden of such infections is increasing evenmore rapidly, and they pose a unique challenge
because their accurate diagnosis and eradication can prove elusive. This review describes the current knowledge re-
garding diagnosis and treatment of periprosthetic joint infection. A number of tools are available to aid in establishing a
diagnosis of periprosthetic joint infection. These include the erythrocyte sedimentation rate, serum C-reactive protein
concentration, synovial white blood-cell count and differential, imaging studies, tissue specimen culturing, and histo-
logical analysis. Multiple definitions of periprosthetic joint infection have been proposed but there is no consensus. Tools
under investigation to diagnose such infections include the C-reactive protein concentration in the joint fluid, point-of-care
strip tests for the leukocyte esterase concentration in the joint fluid, and other molecular markers of periprosthetic joint
infection. Treatment options include irrigation and debridement with prosthesis retention, one-stage prosthesis ex-
change, two-stage prosthesis exchange with intervening placement of an antibiotic-loaded spacer, and salvage treat-
ments such as joint arthrodesis and amputation. Treatment selection is dependent on multiple factors including the
timing of the symptom onset, patient health, the infecting organism, and a history of infection in the joint. Although
prosthesis retention has the theoretical advantages of decreased morbidity and improved return to function, two-stage
exchange provides a lower rate of recurrent infection. As the burden of periprosthetic joint infection increases, the
orthopaedic and medical community should become more familiar with the disease. It is hoped that the tools currently
under investigation will aid clinicians in diagnosing periprosthetic joint infection in an accurate and timely fashion to allow
appropriate treatment. Given the current knowledge and planned future research, the medical community should be
prepared to effectively manage this increasingly prevalent disease.
Background
Periprosthetic joint infection is a devastating complication oftotal joint arthroplasty. In the United States, periprosthetic
joint infection is currently the most common indication for re-
vision total knee arthroplasty and the third most common in-
dication for revision total hip arthroplasty, with an estimated
prevalence of between 1% and 3%1-3. Because of the ease with
which periprosthetic joint infection can develop, it is not an un-
common complication. Pathogen proliferation can easily occur
in the joint space, with the implanted prosthesis as the growth
surface, following the introduction of a small pathogen popula-
tion into the systemic circulation or a wound in the joint.
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Periprosthetic joint infection is typically classified according to
the timing of symptom development and the mechanism of in-
fection as acute postoperative, acute delayed (hematogenous), or
chronic. Treatment algorithms are typically dependent on such a
classification. Presently, the increase in the burden of periprosthetic
joint infection is outpacing developments in prevention4.
Our institution has maintained prospective joint arthro-
plasty databases over the past decade. The use of these databases
has allowed identification of 821 cases of periprosthetic joint
infection among 3308 total revision cases. A substantial
amount of research has been performed with use of these da-
tabases to better understand the care of patients following joint
replacement—specifically prevention, diagnosis, and treat-
ment of periprosthetic joint infection. Based on that work, this
review explores the recent advancements in diagnosis of peri-
prosthetic joint infection and provides guidance in the selec-
tion of a surgical treatment. In spite of the depth of this review,
it will only touch on the oft-described aspects of periprosthetic
joint infection management and will provide the reader with a
complete understanding of the current findings that have the
greatest potential to substantially change patient care.
Current Methods for Diagnosis
Since no highly accurate diagnostic method exists, clinicianshave yet to agree on a ‘‘gold standard’’ for the diagnosis of
periprosthetic joint infection. Currently, diagnosis rests on a
combination of clinical suspicion, serological tests, culture results,
histology, and basic molecular techniques. In large part, current
modalities fall short in providing necessary and accurate infor-
mation on both the existence and the virulence of microorgan-
isms in an infected prosthetic joint. Many groups have attempted
to increase the accuracy of diagnosis by providing definitions
of periprosthetic joint infection that are dependent on criteria
from multiple individual tests5-10. These diagnostic criteria sets,
however, have compounded the problem of diagnosing peri-
prosthetic joint infection since the results provided by different
criteria sets are often not unanimous regarding the diagnosis11.
The currently available sets of diagnostic criteria incor-
porate serological tests (erythrocyte sedimentation rate [ESR]
and C-reactive protein [CRP] concentration), histological
analysis of tissue, the appearance of the joint, culture of intra-
operative tissue samples on a solid medium, and preoperative
aspirate analysis including fluid culture, white blood-cell (WBC)
count, and WBC differential. The utility of these tools has been
investigated repeatedly, and the American Academy of Ortho-
paedic Surgeons (AAOS) recently provided evidence for the use
of each tool in their guidelines for diagnosing periprosthetic
joint infection12. The use of these individual tools, updates in the
definition of periprosthetic joint infection, and the development
of new tools for its diagnosis will be discussed here.
Currently Recommended Diagnostic Tests for Periprosthetic
Joint Infection and the AAOS Algorithm
ESR and serum CRP are very sensitive to the presence of peri-
prosthetic joint infection, and they are used as initial tests even
when there is a low suspicion of such infection12,13. However,
their specificity is relatively low because elevated levels can also
be caused by other inflammatory diseases14. The thresholds for
ESR and serum CRP concentration have previously been cited
as 30 mm/hr and 10 mg/dL, respectively10. However, receiver
operating characteristic (ROC) curve analysis identified the
optimal thresholds for ESR and serumCRP concentration as 31
mm/hr and 2mg/dL, respectively, in a study at our institution13.
These thresholds provided a sensitivity of 96% and a specificity
of 59% when both the ESR and serum CRP concentration were
above these thresholds.
When the ESR or serum CRP concentration is above the
threshold for periprosthetic joint infection in the absence of a
known etiology, continued investigation is warranted. Aspiration
of the joint (under fluoroscopic guidance in the case of the hip)
will often provide a definitive answer to questions raised by ele-
vated serological test results. This is the next step recommended
by the AAOS guidelines, and it is inexpensive12. Cultures from
the aspirated fluid may identify a pathogen for which tailored
treatment can be initiated. However, there is a potential for false
culture results, as will be discussed more thoroughly later in the
section on culture of intraoperative tissue samples. In addition
to culture, the cell count and differential in aspirated fluid should
be determined. A substantial amount of work has been done
in the past decade to identify WBC counts that are predictive of
periprosthetic joint infection5,15-18. That work suggests that aWBC
count of >1700 cells/mL or a polymorphonuclear neutrophil
(PMN) percentage of >65% after the acute postoperative period
is predictive of an infected knee joint12,15,17. Schinsky et al. per-
formed an investigation involving these markers in hip joint as-
pirate and recommended threshold values of >4200 cells/mL for
the WBC count and >80% for the PMN percentage19. Diagnosis
of periprosthetic joint infection during the acute postoperative
period is complicated by the natural increase in inflammatory
markers during this time. Bedair et al. provided threshold values
of 10,700 cells/mL for the synovial WBC count and 89% for the
PMN percentage for the diagnosis of periprosthetic joint infec-
tion during this time period20.
When suspicion of periprosthetic joint infection remains
following initial aspiration and repeat aspiration, yet infection
has not adequately been confirmed, the clinician may utilize
imaging modalities if surgical intervention is not planned. Our
institution participated in a multicenter investigation of the
utility of 18F-labeled fluorodeoxyglucose-positron emission to-
mography (FDG-PET) for differentiating between aseptic and
septic causes of pain in the hip following total hip arthro-
plasty21,22. That study found that FDG-PET had a sensitivity of
85% and a specificity of 93% for diagnosing periprosthetic
joint infection in the hip. Love et al. found a similar utility for
FDG-PET in an analysis of periprosthetic joint infection in
both the hip and the knee23. Other imaging modalities, in-
cluding imaging of labeled leukocytes and gallium imaging,
have been recommended in the AAOS guidelines, but these
recommendations are based on weak to moderate evidence12.
There is no evidence that magnetic resonance imaging (MRI)
and computed tomography (CT) serve a purpose in diagnosing
or characterizing a periprosthetic joint infection.
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If a concrete diagnosis remains elusive after these tools have
been used, the only remaining options are histological analysis of
frozen tissue sections and culture of periprosthetic tissue, both of
which require surgical intervention to examine the surroundings
of the joint. The presence of a sinus tract in communication with
the joint is a well-accepted indicator of periprosthetic joint in-
fection and wouldmerit immediate surgical interventionwithout
the need for further investigation. On the other hand, purulence
in the joint, which has long been well accepted as a marker of
periprosthetic joint infection11,14, should not be taken as an ab-
solute indicator of the presence of infection.We have determined,
in research that has not yet been published, that the sensitivity of
the presence of gross purulence is low (<50%). Although the
false-positive rate for gross purulence could logically be expected
to be low, recent case reports have shown that gross purulence
can be present in patients with a metal hypersensitivity reaction
followingmetal-on-metal total hip arthroplasty24,25. These reports
raise the suspicion that the presence of purulence in a joint (hip
or knee) may be associated with an aseptic allergic reaction to
a foreign material. For this reason, restraint should be exercised
when diagnosing periprosthetic joint infection solely on the basis
of purulent material in the joint.
Our institution does not perform histological analysis of
frozen tissue sections from intra-articular samples. There are
several reasons for this, including the complexity of the test and
high variability of the results between reviewers. Although this
tool has been promoted by many clinicians5,6,8-10,14 and is sup-
ported by the AAOS guidelines12, we question its addition to the
work-up for periprosthetic joint infection in light of the recent
advent of less expensive, more reliable tests such as aspirate
analysis. It can be postulated that the association between the
synovial PMN percentage and the neutrophil concentration in
frozen tissue sections is very high. This hypothesis is unproven,
but if it is true, frozen sections would have little utility in the
diagnosis of periprosthetic joint infection after aspirate analysis
had given ambiguous results, as they would probably neither
confirm nor exclude periprosthetic joint infection but only mimic
the aspirate results. Furthermore, it has been demonstrated by
researchers at our institution and others that Gram stain is not an
effective tool in diagnosing periprosthetic joint infection26,27.
Tissue culturing of intraoperative intra-articular tissue
samples on solid medium has historically been used as the
gold-standard test in diagnosing periprosthetic joint infection.
Nevertheless, numerous patients have a culture-negative peri-
prosthetic joint infection, with an inability to isolate an organ-
ism from cultures reported in 2% to 18% of cases28-33. Inability to
identify the infecting pathogen complicates diagnosis and treat-
ment. Researchers at our institution have found culture-negative
periprosthetic joint infection to be predictive of treatment failure
in patients undergoing irrigation and debridement34. This knowl-
edge has led us to investigate mechanisms to improve the sensi-
tivity of tissue specimen culturing. False-negative results may be
due to selection of inappropriate growth medium for the patho-
gen, biofilm formation, current use of antimicrobial therapy, or
an inadequate culture incubation period. The AAOS guidelines
recommend withholding antimicrobial agents until after tissue
sampling for culture has been performed when there is a high
suspicion of periprosthetic joint infection. Our institution retro-
spectively investigated the effect of preoperative antibiotic ad-
ministration on intraoperative tissue specimen cultures in patients
with previously confirmed periprosthetic joint infection, and it was
found that administration of prophylactic antibiotics did not re-
duce the accuracy of tissue specimen culture results35. Scha¨fer et al.
and Neut et al. showed that a longer culture incubation period
improved the sensitivity of tissue specimen culture (from 63% to
64% after one week to 77% after twoweeks)36,37. One concernwith
increasing the culture incubation period is the risk of false-positive
results due to contamination. However, Scha¨fer et al. showed that
>50% of contaminants were isolated in the first week of a two-
week culture36. More importantly, their analysis showed that
nonstandard pathogens were more likely to be isolated during the
second week of incubation. Contamination of tissue specimen
cultures resulting in a false-positive result occurs in 5% to 37% of
periprosthetic joint infection cases38-43. Contamination is a real
concern for the surgeon as it may subject the patient to unnec-
essary or more complicated surgery.
Definition of Periprosthetic Joint Infection
Despite their shortcomings, multiple tools for differentiating
between periprosthetic joint infection and other diseases are at
the disposal of the medical community. Although the AAOS
guidelines provide direction in utilizing these tools, a definition
of periprosthetic joint infection is necessary to permit com-
parisons among research studies and to provide the clinician
with a definitive diagnosis when investigating a suspected
periprosthetic joint infection. For this reason, multiple aca-
demic researchers have taken it upon themselves to provide a
definition of periprosthetic joint infection based on the pre-
viously discussed diagnostic tools5-10. To date, these definitions
have not incorporated the synovial aspirate cell count and
differential. For this reason, we proposed a new definition of
periprosthetic joint infection that incorporated aspirate anal-
ysis and attempted to improve the definition of a positive tissue
specimen culture11. As no gold-standard definition of peri-
prosthetic joint infection exists, our proposed definition was
analyzed by comparison with the existing definitions. In ad-
dition, the results based on existing definitions were compared
among themselves. That analysis found that in 24% of cases, at
least one existing definition resulted in diagnosis of a peri-
prosthetic joint infection while another well-accepted defini-
tion resulted in a diagnosis involving an aseptic etiology. This
suggests that a diagnosis of periprosthetic joint infection may
often be dependent on which well-regarded definition is being
utilized, complicating comparisons among research studies
that utilize different diagnostic definitions of periprosthetic
joint infection. Our proposed definition of periprosthetic joint
infection had an accuracy of 53% to 100% compared with
existing definitions.
As previously discussed, our institution does not utilize
histological tissue analysis, and this has therefore not been in-
corporated into our proposed definition of periprosthetic joint
infection. Furthermore, as discussed above, it is suggested that
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purulence serves a limited purpose and may result in misdiag-
nosis of periprosthetic joint infection. The Musculoskeletal In-
fection Society recently released a definition of periprosthetic
joint infection44. It is hoped that this definitionwill be adopted as
the gold-standard definition of periprosthetic joint infection and
will provide uniformity in this field (Fig. 1).
As improvements continue to be made in the uniformity
and accuracy of definitions of periprosthetic joint infection
based on current diagnostic tools, other diagnostic tools con-
tinue to be developed. The tools investigated at our institution
are discussed below and, if and when their efficacy is proven,
their incorporation into the definition of periprosthetic joint
infection will further improve the ability to diagnose peri-
prosthetic joint infection in an accurate and timely fashion.
Leukocyte Esterase
As reported above, the combination of synovial fluid leukocyte
count and neutrophil differential has been reported to have high
sensitivity and specificity in the diagnosis of infection after total
knee arthroplasty. It is therefore reasonable to expect an increase
in the synovial concentration of enzymes specific to these white
blood cells and to neutrophils in particular. Our institution
conducted a prospective study that revealed one of these en-
zymes, leukocyte esterase, to be a highly accurate predictor of
periprosthetic joint infection45. Synovial fluid was collected in-
traoperatively, prior to arthrotomy, in knee revision arthro-
plasties performed over a period of three years. At the time of
collection, the synovial fluid was applied to a colorimetric strip
test that is commonly used to test for urinary tract infection (Fig.
2). The results were stratified into four separate categories on the
basis of the degree of color change in the strip (representing the
concentration of leukocyte esterase in the sample). Peri-
prosthetic joint infection was defined in the study according to a
modification of our diagnostic criteria incorporating aspirate cell
count analysis11. Compared with these criteria, the highest cat-
egory of leukocyte esterase concentration (11) was 81% sen-
sitive and 100% specific. Alternatively, when the two highest
categories of leukocyte esterase concentration (1 and11) were
considered positive, the strip was 94% sensitive and 87% spe-
cific. Similar results were seenwhen aspirationwas performed in
Fig. 1
The Musculoskeletal Infection Society’s new algorithm for diagnosis of periprosthetic joint infection (PJI)44. P. acnes = Propionibacterium acnes.
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the clinic prior to surgery. The leukocyte esterase concentration
also showed a high correlationwith the ESR, CRP, synovialWBC
count, and synovial PMN percentage.
Although this research is in its infancy, there is great
promise that the use of colorimetric strips will provide the
surgeon with another tool for accurately diagnosing or ruling
out joint infection. This strip test has the advantages of being
inexpensive and providing immediate results. Instant results
are invaluable to the clinician and to the surgeon intraoperatively,
and other instant-result tests have failed to prove to be useful to
date26,27.
Other Molecular Markers of Periprosthetic Joint Infection
As leukocyte esterase has proven itself to be a useful tool in
diagnosing periprosthetic joint infection, the addition of other
molecular markers has the potential to further increase the ac-
curacy of diagnosis. For this reason, commonly known proteins
in inflammatory pathways were also investigated. Identification
of additional molecular markers in the synovial fluid that are
predictive of periprosthetic joint infection has the potential to
lead to the development of other rapid tests similar to the preg-
nancy and urinary tract infection dipstick tests.
A study was performed at our institution to assess the
utility of forty-six well-known inflammatory proteins in sam-
ples of synovial fluid obtained prior to arthrotomy in seventy-
four revision arthroplasty procedures, thirty-one of which were
classified as septic and forty-three as aseptic according to our
institutional criteria46. A proteomics analysis was conducted to
determine the concentrations of the inflammatory proteins in
each sample, and ROC curve analysis was used to establish the
optimal threshold of each potential marker for diagnosing
periprosthetic joint infection. This analysis indicated that five
proteins could be considered highly accurate indicators of
periprosthetic joint infection: interleukin-6 (IL-6), IL-8, CRP,
a-2 macroglobulin, and vascular endothelial growth factor
(VEGF). Using the optimal threshold of 4270 pg/mL, IL-6 was
the most accurate predictor of periprosthetic joint infection,
with a sensitivity of 87% and a specificity of 100%46. This work
confirmed similar findings by Deirmengian et al., who studied
a series of twenty-three potential biomarkers of periprosthetic
joint infection47. In both analyses, IL-6 was the most accurate
predictor of periprosthetic joint infection.
Our research remains under way, with plans for an in-
creased sample size and the inclusion of multiple institutions.
The long-term potential for development of a quick, accurate
diagnostic test for periprosthetic joint infection, supplement-
ing the existing diagnostic criteria and the leukocyte esterase
test, represents an enormous opportunity to improve man-
agement of patients, decrease cost, and relieve the ambiguity
currently involved in treating a failed total joint arthroplasty.
Synovial CRP Concentration
The CRP concentration in serum is a well-accepted tool in the
investigation of suspected periprosthetic joint infection13,48.
However, as previously described, serum CRP has low specificity
as a marker of periprosthetic joint infection. It was postulated
that this inflammatory marker, which is a known marker of
periprosthetic joint infection, would be more definitively ele-
vated at the arthroplasty site. For this reason, an investigation of
the synovial CRP concentration as a predictor of periprosthetic
joint infection was undertaken at our institution.
Synovial fluid samples were collected intraoperatively
during aspiration prior to arthrotomy in sixty-six revision knee
arthroplasties performed over the course of a single year49.
Again, revisions were classified as septic or aseptic according to
our institution’s set of diagnostic criteria11. ROC curve analysis
indicated the optimal CRP threshold to be 3.7 mg/L in the joint
fluid compared with 16.5 mg/L in the serum in the same subset
of patients. The sensitivity of the CRP concentration in the
synovial fluidwas 84%, the specificity was 97%, and the accuracy
was 96%. The synovial CRP concentration was a superior pre-
dictor of periprosthetic joint infection compared with the serum
CRP concentration, which had a sensitivity of 76%, a specificity
of 93%, and an accuracy of 91%49.
These findings, although preliminary, provide yet another
avenue for improving the early diagnosis of periprosthetic joint
infection and decreasing false-negative diagnoses. As with the
previously mentioned work, this research is continuing at ad-
ditional centers and the expectation is that synovial CRP will
prove itself and become incorporated into the diagnostic algo-
rithm for periprosthetic joint infection. The advantage of testing
for synovial CRP is that this marker can be readily measured in
all hospital clinical laboratories and can be easily utilized without
development of novel technologies or training of additional staff.
In addition, the outcome of this test is not heavily dependent on
the operator and can be universally compared among clinics.
Current Methods for Treatment
Accurate and timely diagnosis of periprosthetic joint infec-tion is essential as its treatment is an urgent matter. Fur-
thermore, the treatment for aseptic failure of an arthroplasty
varies greatly from that required for eradication of periprosthetic
joint infection. Once the diagnosis of periprosthetic joint in-
fection is confirmed, the characteristics of the infection must
be elicited. These include the duration of symptoms, patient
immune status and overall health characteristics, history of
Fig. 2
Leukocyte esterase strip test showing purple 11, dark pink 1, and light
yellow negative results.
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periprosthetic joint infection in the current joint and all other
joints, status of any joint wound, joint function expectations,
and characteristics of the infecting organism. These data will
dictate the surgical treatment selection (Fig. 3).
When surgery would present a great risk to patients be-
cause of their state of health and the infection is caused by a
pathogen that is of low virulence and susceptible to antimi-
crobial agents, antibiotic suppression alone may be the best
treatment option. There is a lack of evidence for treatment of
patients solely with antibiotics, without surgical intervention.
Despite this lack of literature support, patients who cannot
tolerate surgery are without options other than attempts to
control the periprosthetic joint infection with antimicrobial
agents. Chronic antibiotic suppression is also indicated in pa-
tients with persistent periprosthetic joint infection following
surgical debridement if they decline or cannot tolerate subse-
quent surgery. Infection control has been shown to be mod-
erately successful in this patient population50-53.
Two-stage exchange—resection of the implants, placement
of a temporary antibiotic-impregnated cement spacer, and de-
layed component reimplantation—is the gold-standard treatment
for periprosthetic joint infection in North America. However,
retention of the original prosthesis could provide decreased
morbidity and improved return to function. Irrigation and de-
bridement with retention of the prosthesis is traditionally indi-
cated in patients with acute onset of symptoms, a well-fixed and
aligned implant, an antibiotic-susceptible organism, and sufficient
soft-tissue coverage54. Our institution has studied the outcome of
this treatment method34,55-60. No statistically significant difference
in outcome could be identified among acute postoperative, acute
hematogenous, and chronic infections in multiple investigations
of irrigation and debridement for the treatment of periprosthetic
joint infection34,55. However, it is possible that these studies
were underpowered and unable to detect actual differences.
These analyses did identify staphylococcal infection as an inde-
pendent predictor of failure of treatment involving irrigation and
Fig. 3
Algorithmutilized for periprosthetic joint infection treatment at our institution. THA= total hip arthroplasty, TKA= total kneearthroplasty, I&D= irrigation and
debridement, Min. =minimum, IV = intravenous, gr = grams, MRSA =methicillin-resistant Staphylococcus aureus, and PMMA = polymethylmethacrylate.
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debridement with implant retention. Deirmengian et al. also
supported this finding61. Furthermore, two separate studies that
included our institution indicated poor eradication rates (16%
and 37%) formethicillin-resistant Staphylococcus aureus (MRSA)
after irrigation and debridement with implant retention58,60. In
another study, streptococcal infections—which have historically
been believed to be well treated with irrigation and debridement
with implant retention—had an eradication rate (65%) that was
comparable with that of all other organisms (71%)56.
These recent additions to our knowledge regarding peri-
prosthetic joint infection treatment suggest a decreased utility
for surgical intervention with prosthesis retention. Our institu-
tion’s treatment algorithm provides an opportunity for irrigation
and debridement with one-stage prosthesis exchange for the
treatment of a non-MRSA periprosthetic joint infection occur-
ring during the acute postoperative period (within two weeks)
after cementless total hip arthroplasty. Although the effective-
ness of such treatment remains unknown, the removal of the
implant before it has becomewell fixed allows formore extensive
debridement and for removal of the pathogen’s growth surface.
As it is apparent that irrigation and debridement with
prosthesis retention has become a stepping stone to two-stage
exchange, it should be noted that a multicenter study including
our institution found a lower eradication rate following two-stage
exchange of a knee prosthesis in patients who had undergone a
prior irrigation and debridement compared with patients treated
directly with two-stage implant exchange57. A subsequent study at
our institution found no difference in the outcome of two-stage
exchange of a hip prosthesis depending on whether or not prior
irrigation and debridement had been performed. Furthermore,
our institution has reported similar functional outcomes after
total knee revision for septic and aseptic causes62.
The orthopaedic community currently lacks a concrete
prognostic classification for the outcome of treating peri-
prosthetic joint infection. Efforts have beenmade to fill this void,
beginning with predictors of recurrent or persistent infection
after two-stage knee revision63. That investigation found culture-
negative periprosthetic joint infection, a methicillin-resistant
pathogen, and increased operative time during reimplantation to
be independent predictors of recurrence of the infection. In a
separate study, two-stage revision to treat a periprosthetic joint
infection caused by a gram-negative pathogen was found to have
as low a success rate (52%) as two-stage treatment of an infection
caused by MRSA (51%), whereas the success rate for treatment
of methicillin-sensitive gram-positive organisms (69%) was
considerably better64. This, combined with recent findings,
illustrates the poor outcome of even the gold-standard treatment
(two-stage exchange) for periprosthetic joint infection.
Because of the high failure rate of periprosthetic joint
infection treatment, patients often present with recurrent in-
fection following two-stage exchange. This presents a challenge
to the treating surgeon as few surgical options, including a repeat
two-stage exchange, remain. It has been our experience that
repeat two-stage exchange does provide patients with a reason-
able expectation of infection control. In a study of repeat two-
stage exchange of a knee prosthesis at our institution, fourteen
of eighteen patients remained free of infection at a minimum of
two years, and two of the four failures were successfully treated
with a third two-stage exchange65. In a separate study involving
the hip, only eight of fifteen patients undergoing repeat resection
underwent reimplantation, but seven of these eight patients
remained free of infection. In comparison, eradication of the
infection failed in seven of eleven patients treated with repeat
two-stage exchange of a hip prosthesis in a study by Kalra et al.66.
Salvage proceduresmust be considered in the event of repeat
failure of treatment for periprosthetic joint infection in patients
with a limited probability of a functional joint on reimplantation, a
compromised immune system, or a quality of health that precludes
multiple surgeries. Salvage procedures in the knee include ar-
throdesis and above-the-knee amputation. Both procedures have
the potential to eradicate the periprosthetic joint infection and
produce a functioning limb. A multicenter analysis including our
institution indicated moderate success following above-the-knee
amputation secondary to periprosthetic joint infection67. Although
the study cohort was small, it appeared that the patient’s quality of
life was dependent on use of a prosthesis. It is important to un-
derstand that internal fixation during knee arthrodesis for the
treatment of periprosthetic joint infection can result in the for-
mation of a biofilmon this implant and lead to persistent infection;
thus, the use of external fixation should be considered despite the
higher rate of nonunion. At this time, salvage procedures for the
hip are limited to arthrodesis, which requires the use of plate
fixation. Surgeons should therefore be mindful of the likely need
for continued chronic antibiotic suppression in these patients.
Discussion
As the burden of periprosthetic joint infection trends up-ward, it is likely that an increasing number of clinicians and
surgeons will encounter this disease. If prevention fails, meeting
this burden will require improved detection and treatment on
the part of all physicians and substantial efforts by academic
researchers to enhance these tools. This review has outlined
many of the recent developments in the diagnosis and treatment
of periprosthetic joint infection. The tools of the diagnostician
are constantly changing, with addition of the highly accurate
synovial fluid analysis technique during the past decade and the
likely addition of other biomarkers and instant-result dipsticks
in the next decade. Further work is needed to fully understand
the prognostic factors associated with successful treatment of
this debilitating disease. Given the current knowledge outlined in
this review and the investigations planned for the future, it does
not seem unrealistic to expect that the orthopaedic community
and its medical partners can meet this burden. n
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